1y return+16.0%S&P 500 +20.9%
3y return+45.1%S&P 500 +68.5%
5y return−55.9%S&P 500 +74.5%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since December 31, 2020: $31 against $200 in the S&P 500.2
Euclidean Capital LLCS&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| VEUVanguard Intl Equity Index F | $271.6M | 61.8% | |
| VTVVanguard Index Fds | $113.3M | 25.8% | |
| INDAIshares Tr | $18.3M | 4.2% | |
| ORICOric Pharmaceuticals Inc | $10.7M | 2.4% | |
| TMSTeamshares Inc | $9.0M | 2.1% | New |
| FHTXFoghorn Therapeutics Inc | $7.7M | 1.7% | |
| PMVPPmv Pharmaceuticals Inc | $3.5M | 0.8% | |
| ALECAlector Inc | $2.6M | 0.6% | |
| SRZNSurrozen Inc | $2.3M | 0.5% | |
| TNYATenaya Therapeutics Inc | $751K | 0.2% | |
| Surrozen IncCUSIP 86889P117 | $2,819 | 0.0% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| SRZNSurrozen Inc | December 31, 2023 | +176.1% | $2.3M |
| VEUVanguard Intl Equity Index F | September 30, 2024 | +32.9% | $271.6M |
| INDAIshares Tr | December 31, 2022 | +18.3% | $18.3M |
| VTVVanguard Index Fds | December 31, 2025 | +14.1% | $113.3M |
| Surrozen IncCUSIP 86889P117 | September 30, 2023 | −59.9% | $2,819 |
| ORICOric Pharmaceuticals Inc | December 31, 2020 | −68.0% | $10.7M |
| FHTXFoghorn Therapeutics Inc | December 31, 2020 | −75.9% | $7.7M |
| ALECAlector Inc | December 31, 2020 | −86.7% | $2.6M |
| TNYATenaya Therapeutics Inc | September 30, 2021 | −96.4% | $751K |
| PMVPPmv Pharmaceuticals Inc | December 31, 2020 | −97.8% | $3.5M |
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +9.8% | +14.8% |
| March 31, 2026 | +2.5% | −4.6% |
| December 31, 2025 | +0.8% | +2.4% |
| September 30, 2025 | +2.2% | +7.8% |
| June 30, 2025 | +11.2% | +10.5% |
| March 31, 2025 | −4.2% | −4.6% |
| December 31, 2024 | −1.7% | +2.1% |
| September 30, 2024 | +5.9% | +5.4% |
| June 30, 2024 | +2.1% | +4.0% |
| March 31, 2024 | +6.6% | +10.0% |
| December 31, 2023 | +10.6% | +11.2% |
| September 30, 2023 | −6.2% | −3.6% |
| June 30, 2023 | +6.5% | +8.3% |
| March 31, 2023 | −12.8% | +7.0% |
| December 31, 2022 | −22.4% | +7.1% |
| September 30, 2022 | −8.4% | −5.3% |
| June 30, 2022 | −27.9% | −16.5% |
| March 31, 2022 | −27.4% | −4.9% |
| December 31, 2021 | −7.6% | +10.7% |
| September 30, 2021 | −4.8% | +0.3% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Euclidean Capital LLC Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1825034&type=13F-HR&dateb=&owner=include&count=40CIK 1825034
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1825034/000101297526000776/Filed August 14, 2026 · accession 0001012975-26-000776